Study of Midomafetamine in Healthy Adults
Clinical trial NCT07584720 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07584720
- Sponsor
- Resilient Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2026-07-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.